Disrupted N-linked Glycosylation As a Disease Mechanism in Deficiency of ADA2.

Pui Y Lee,Yuelong Huang,Qing Zhou,Oskar Schnappauf,Michael S Hershfield,Ying Li,Nancy J Ganson,Natalia Sampaio Moura,Ottavia M Delmonte,Scellig S Stone,Michael J Rivkin,Sung-Yun Pai,Todd Lyons,Robert P Sundel,Victor W Hsu,Luigi D Notarangelo,Ivona Aksentijevich,Peter A Nigrovic
DOI: https://doi.org/10.1016/j.jaci.2018.05.038
2018-01-01
Abstract:Deficiency of adenosine deaminase 2 (DADA2) causes systemic inflammation, immunodeficiency, vasculitis, and early-onset strokes.1,2 This variable phenotype is caused by recessively inherited loss-of-function mutations of CECR1 (cat eye syndrome chromosome region 1), which encodes adenosine deaminase 2 (ADA2). At least 30 pathogenic mutations in the CECR1 gene have described in more than 125 patients.3,4 Although absent plasma ADA2 activity is a hallmark of the disease, how individual mutations affect ADA2 expression and function has been largely unexplored.
What problem does this paper attempt to address?